Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor
- 1 March 2003
- journal article
- case report
- Published by Elsevier in Fertility and Sterility
- Vol. 79 (3) , 628-631
- https://doi.org/10.1016/s0015-0282(02)04761-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Overexpression of Aromatase P450 in Leiomyoma Tissue Is Driven Primarily through Promoter I.4 of the Aromatase P450 Gene (CYP19)Journal of Clinical Endocrinology & Metabolism, 2002
- Inhibition of in Situ Expression of Aromatase P450 in Leiomyoma of the Uterus by Leuprorelin AcetateJournal of Clinical Endocrinology & Metabolism, 2001
- In Situ Estrogen Synthesized by Aromatase P450 in Uterine Leiomyoma Cells Promotes Cell Growth Probably Via an Autocrine/Intracrine Mechanism*Endocrinology, 2000
- Clinical Decision Making Regarding Leiomyomata: What We Need in the Next MilleniumEnvironmental Health Perspectives, 2000
- Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas [published erratum appears in Hum Reprod 1998 Mar;13(3):780]Human Reproduction, 1997
- Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial culturesJournal of the Society for Gynecologic Investigation, 1995
- Is there a role for estrogen in follicular maturation in the primate?Endocrine, 1995
- Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on follicular maturation induced by pregnant mare serum gonadotrophin in the immature ratJournal of Endocrinology, 1994
- Treatment of uterine fibroids: Current findings withgonadotropin-releasing hormone agonistsAmerican Journal of Obstetrics and Gynecology, 1992
- A New Cause of Female Pseudohermaphroditism: Placental Aromatase DeficiencyJournal of Clinical Endocrinology & Metabolism, 1991